Corgi Data & Surveillance ETF EYES

Full chart Compare
Set alert

Price alert · EYES

All alert types
29.25 USD -0.68 (-2.28%)

At closeNov 3, 2026, 4:10 PM EST

29.25 0.00 0.00%

After hours · Nov 3, 4:10 PM ET

28.74 Day range 29.35
23.90 52-week range 1,098.90
YTD
-97.34%
1 year
-97.34%
Market cap
54.38M
EPS (ttm)
0.876459
Shares out
13.14M
P/E ratio
33.37
Forward P/E
-2.96
YTD return
-97.34%
1-year return
-97.34%
Volume
1.17K
Avg volume
2.24K
Open
28.74
Previous close
29.93
Day's range
28.74 – 29.35
52-week range
23.90 – 1,098.90
Beta
2.56
Analysts
Buy
Earnings date
Aug 13, 2020

2Y -1,069.65 (-97.34%)

05001,000May 26Jun 26Aug 26Sep 26Oct 2629.25

Key statistics

Enterprise value
-1.84M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.86
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-6.09M
Total cash
56.38M
Total debt
151.00K
Return on equity
-13.42%
Short % of float
3.85%
50-day average
5.83
200-day average
5.13

Analyst view

Consensus: buy

Buy
Price target (mean) —
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Aug 13, 2020

Expected Aug 13, 2020. Consensus EPS estimate 0.00.

Earnings history

Earnings

EYES recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 13, 2020Jun 1, 20200.00———
Jul 1, 2020Mar 1, 2020-0.40———

Upgrades / downgrades

EYES analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2020Dougherty & Co.init—Buy
Nov 25, 2020Rodman & Renshawmain—Buy
Nov 25, 2020Rodman & Renshawinit—Buy
Nov 25, 2020H.C. Wainwrightinit—Buy

About Corgi Data & Surveillance ETF

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on EYES — it syncs with the Stock Master app.

Insider holders

EYES insider holders
InsiderRelationLatest transactionDateShares held
BLAKE JOHN TChief Financial OfficerConversion of Exercise of derivative securityFeb 18, 20201,754
DORN JESSY DANAOfficerStock Award(Grant)Nov 28, 20191,458
LARSON ALEXANDRA L.P.DirectorStock Award(Grant)Jun 8, 2021500
LINK WILLIAM JDirectorStock Award(Grant)May 31, 2018115,186
MCGUIRE JONATHAN WILLChief Executive OfficerSaleFeb 19, 202023,826
MENDELSOHN AARONDirectorStock GiftApr 12, 20210

Institution ownership

EYES institution ownership
Holder% heldSharesValueReported
Vanguard Group, Inc. (The)0.76%299,1191.24MJun 29, 2022
Geode Capital Management, LLC0.22%85,441353.73KJun 29, 2022
Morgan Stanley0.20%77,558321.09KJun 29, 2022
Susquehanna Fundamental Investments, LLC0.15%60,390250.01KMar 30, 2022
Millennium Management Llc0.09%33,952140.56KJun 29, 2022
State Street Corporation0.07%27,698114.67KJun 29, 2022

Fund ownership

EYES fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.13%51,814214.51KJun 29, 2022
Fidelity Total Market Index Fund0.04%14,82261.36KJun 29, 2022
Fidelity Series Total Market Index Fund0.02%8,91736.92KJun 29, 2022
Fidelity NASDAQ Composite Index Fund0.01%3,02612.53KJun 29, 2022
EQ Advisors Trust-1290 VT Micro Cap Port0.00%1,2135.02KJun 29, 2022
John Hancock Var Ins Tr-Total Stock Market Index Tr0.00%4221.75KMar 30, 2022